(a) An ephedrine combination product, pseudoephedrine, and phenylpropanolamine, as defined in § 5-64-1105 , are designated Schedule V controlled substances in addition to the drugs and other substances listed in Schedule V of the List of Controlled Substances for the State of Arkansas promulgated by the Secretary of the Department of Health. (b) The Schedule V classification does not apply to: (1) An exempt product described in § 5-64-1103(b)(1) ; or (2) Any ephedrine or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form described in § 5-64-1103(b)(2) . (c) The secretary may reschedule a product described in subdivision (b)(1) or subdivision (b)(2) of this section if it is determined that the conversion of the active ingredient in the product into methamphetamine or its salts or precursors is feasible. (d) A wholesale distributor with exclusive rights to distribute pseudoephedrine to only licensed pharmacies is exempt from Schedule V requirements for the storage and distribution of pseudoephedrine. Amended by Act 2019, No. 910,§ 4839, eff. 7/1/2019. Amended by Act 2019, No. 910,§ 4838, eff. 7/1/2019. Acts 2005, No. 256, § 2; 2011, No. 588, § 1. (a) An ephedrine combination product, pseudoephedrine, and phenylpropanolamine, as defined in § 5-64-1105 , are designated Schedule V controlled substances in addition to the drugs and other substances listed in Schedule V of the List of Controlled Substances for the State of Arkansas promulgated by the Secretary of the Department of Health. (b) The Schedule V classification does not apply to: (1) An exempt product described in § 5-64-1103(b)(1) ; or (2) Any ephedrine or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form described in § 5-64-1103(b)(2) . (c) The secretary may reschedule a product described in subdivision (b)(1) or subdivision (b)(2) of this section if it is determined that the conversion of the active ingredient in the product into methamphetamine or its salts or precursors is feasible. (d) A wholesale distributor with exclusive rights to distribute pseudoephedrine to only licensed pharmacies is exempt from Schedule V requirements for the storage and distribution of pseudoephedrine. Amended by Act 2019, No. 910,§ 4839, eff. 7/1/2019. Amended by Act 2019, No. 910,§ 4838, eff. 7/1/2019. Acts 2005, No. 256, § 2; 2011, No. 588, § 1. (a) An ephedrine combination product, pseudoephedrine, and phenylpropanolamine, as defined in § 5-64-1105 , are designated Schedule V controlled substances in addition to the drugs and other substances listed in Schedule V of the List of Controlled Substances for the State of Arkansas promulgated by the Secretary of the Department of Health. (b) The Schedule V classification does not apply to: (1) An exempt product described in § 5-64-1103(b)(1) ; or (2) Any ephedrine or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form described in § 5-64-1103(b)(2) . (c) The secretary may reschedule a product described in subdivision (b)(1) or subdivision (b)(2) of this section if it is determined that the conversion of the active ingredient in the product into methamphetamine or its salts or precursors is feasible. (d) A wholesale distributor with exclusive rights to distribute pseudoephedrine to only licensed pharmacies is exempt from Schedule V requirements for the storage and distribution of pseudoephedrine. Amended by Act 2019, No. 910,§ 4839, eff. 7/1/2019. Amended by Act 2019, No. 910,§ 4838, eff. 7/1/2019. Acts 2005, No. 256, § 2; 2011, No. 588, § 1. (a) An ephedrine combination product, pseudoephedrine, and phenylpropanolamine, as defined in § 5-64-1105 , are designated Schedule V controlled substances in addition to the drugs and other substances listed in Schedule V of the List of Controlled Substances for the State of Arkansas promulgated by the Secretary of the Department of Health. (b) The Schedule V classification does not apply to: (1) An exempt product described in § 5-64-1103(b)(1) ; or (2) Any ephedrine or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form described in § 5-64-1103(b)(2) . (1) An exempt product described in § 5-64-1103(b)(1) ; or (2) Any ephedrine or pseudoephedrine in liquid, liquid capsule, or liquid gel capsule form described in § 5-64-1103(b)(2) . (c) The secretary may reschedule a product described in subdivision (b)(1) or subdivision (b)(2) of this section if it is determined that the conversion of the active ingredient in the product into methamphetamine or its salts or precursors is feasible. (d) A wholesale distributor with exclusive rights to distribute pseudoephedrine to only licensed pharmacies is exempt from Schedule V requirements for the storage and distribution of pseudoephedrine. Acts 2005, No. 256, § 2; 2011, No. 588, § 1.
‹ Prev All Arkansas sections Next ›
Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.